Accelerating cell therapy production: realizing the advantages of rapid analytical testing solutions

Cell therapy is experiencing rapid growth, with an increasing number of treatments receiving marketing approval every year. One notable area is CAR-T cell therapy, which requires a complex ex vivo workflow. Many different areas of this workflow could benefit from analytical testing beyond what is required for regulatory compliance.

Please enter your email to access content Read now